United States & Canada International
Home PageMagazineTravelPersonalsAbout
Advertise with us     Subscriptions     Contact us     Site map     Translate    

 
Table Of Contents
January 2002 Cover
January 2002 Cover

 HIV Digest HIV Digest Archive  
January 2002 Email this to a friend
Check out reader comments

Delaying HIV drugs may be okay for some

Symptom-free HIV patients can safely hold off taking AIDS drugs longer than previously thought, two new studies suggest.

When antiretroviral drugs first became available in the mid-1990s, their dramatic effects prompted many doctors to recommend immediate treatment for all HIV patients to keep the virus in check.

However, the drugs are costly, must be switched often to remain effective and can cause serious side effects, so doctors have sought to delay treatment whenever possible.

View our poll archive
Recently revised guidelines indicated the drugs could be started when levels of disease-fighting CD4 white blood cells dropped to 350 per cubic millimeter instead of the previously recommended 500.

The new studies suggest the drugs can still be effective if started when the patient's CD4 count is even lower-- at least 200-- and even if there are high levels of virus circulating in the blood. The studies found that for many patients, delaying treatment does no harm.

In one study, researchers analyzed data from 3,226 patients treated in European HIV clinics from 1996 to 2000.

Patients began treatment with at least three HIV drugs and were followed for an average of more than two years. Eighty-five percent-- 2,741-- reached undetectable virus levels by 32 weeks. Those who started out with CD4 counts between 200 and 349 fared just as well as those with initial counts of 350 or higher.

It took longer for the drugs to suppress the virus in patients who initially had more than 100,000 copies of virus per milliliter of plasma. But they were just as likely as those with lower initial virus levels to reach undetectable levels at 32 weeks.

The second study involved 1,219 HIV patients who started triple-drug treatment between 1996 and 1999.

By September 2000, 82 had died of AIDS-related causes. Most deaths were in patients whose initial CD4 counts were less than 200-- the bulk in those with counts less than 50. Those whose initial counts were around 200 fared just as well as those with higher levels.

Editor's Note: from the Associated Press


Guidemag.com Reader Comments
You are not logged in.

No comments yet, but click here to be the first to comment on this HIV Digest!

Custom Search

******


My Guide
Register Now!
Username:
Password:
Remember me!
Forget Your Password?




This Month's Travels
Travel Article Archive
Seen in Orlando
Daren, Gil, Tony & Greg at Parliament House Hotel, Orlando

Seen in San Diego

Wet boxers at Flicks

Seen in Fort Lauderdale

A fierce pride of performers at Johnny's



From our archives


Baltimore's once-vibrant sex scenes evaporate


Personalize your
Guidemag.com
experience!

If you haven't signed up for the free MyGuide service you are missing out on the following features:

- Monthly email when new
   issue comes out
- Customized "Get MyGuys"
   personals searching
- Comment posting on magazine
   articles, comment and
   reviews

Register now

 
Quick Links: Get your business listed | Contact us | Site map | Privacy policy







  Translate into   Translation courtesey of www.freetranslation.com

Question or comments about the site?
Please contact webmaster@guidemag.com
Copyright © 1998-2008 Fidelity Publishing, All rights reserved.